These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 2247619)
21. Solid- and liquid-phase extraction for the gas chromatographic-tandem mass spectrometric quantification of 2,3-dinor-thromboxane B2 and 2,3-dinor-6-oxo-prostaglandin F1 alpha in human urine. Tsikas D; Gutzki FM; Böhme M; Fuchs I; Frölich JC J Chromatogr A; 2000 Jul; 885(1-2):351-9. PubMed ID: 10941682 [TBL] [Abstract][Full Text] [Related]
22. Renal prostacyclin and thromboxane in normotensive and preeclamptic pregnant women and their infants. Ylikorkala O; Pekonen F; Viinikka L J Clin Endocrinol Metab; 1986 Dec; 63(6):1307-12. PubMed ID: 3536979 [TBL] [Abstract][Full Text] [Related]
23. Increased prostacyclin production during exercise in untrained and trained men: effect of low-dose aspirin. Böger RH; Bode-Böger SM; Schröder EP; Tsikas D; Frölich JC J Appl Physiol (1985); 1995 May; 78(5):1832-8. PubMed ID: 7649919 [TBL] [Abstract][Full Text] [Related]
24. In vivo platelet activation in beta-thalassemia major reflected by increased platelet-thromboxane urinary metabolites. Eldor A; Lellouche F; Goldfarb A; Rachmilewitz EA; Maclouf J Blood; 1991 Apr; 77(8):1749-53. PubMed ID: 2015401 [TBL] [Abstract][Full Text] [Related]
25. Cigarette smoking: profiles of thromboxane- and prostacyclin-derived products in human urine. Barrow SE; Ward PS; Sleightholm MA; Ritter JM; Dollery CT Biochim Biophys Acta; 1989 Oct; 993(1):121-7. PubMed ID: 2679889 [TBL] [Abstract][Full Text] [Related]
26. Application of an alpha-sidechain length-specific monoclonal antibody to immunoaffinity purification and enzyme immunoassay of 2,3-dinor-6-keto-prostaglandin F1 alpha from human urine. Hiramatsu M; Hayashi Y; Yamamoto S; Hayashi A; Sawada M; Hamanaka N; Yamashita K Prostaglandins Leukot Essent Fatty Acids; 1994 Feb; 50(2):69-79. PubMed ID: 8171070 [TBL] [Abstract][Full Text] [Related]
27. Urinary thromboxane A2/prostacyclin balance reflects the pathological state of a diabetic. Hishinuma T; Koseki Y; Murai Y; Yamazaki T; Suzuki K; Mizugaki M Prostaglandins Other Lipid Mediat; 1999 Nov; 58(5-6):263-71. PubMed ID: 10593168 [TBL] [Abstract][Full Text] [Related]
28. Renal prostacyclin biosynthesis is reduced in children with hemolytic-uremic syndrome in the context of systemic platelet activation. Noris M; Benigni A; Siegler R; Gaspari F; Casiraghi F; Mancini ML; Remuzzi G Am J Kidney Dis; 1992 Aug; 20(2):144-9. PubMed ID: 1496967 [TBL] [Abstract][Full Text] [Related]
29. Abnormal prostanoid metabolism in lupus nephritis and the effects of a thromboxane A2 synthetase inhibitor, DP-1904. Yoshida T; Ichikawa Y; Tojo T; Homma M Lupus; 1996 Apr; 5(2):129-38. PubMed ID: 8743126 [TBL] [Abstract][Full Text] [Related]
30. The effect of short-term diets rich in fish, red meat, or white meat on thromboxane and prostacyclin synthesis in humans. Mann N; Sinclair A; Pille M; Johnson L; Warrick G; Reder E; Lorenz R Lipids; 1997 Jun; 32(6):635-44. PubMed ID: 9208393 [TBL] [Abstract][Full Text] [Related]
31. Stimulation of prostacyclin synthesis by physical exercise in type I diabetes. Koivisto VA; Jantunen M; Sane T; Helve E; Pelkonen R; Viinikka L; Ylikorkala O Diabetes Care; 1989 Oct; 12(9):609-14. PubMed ID: 2507264 [TBL] [Abstract][Full Text] [Related]
32. Urinary excretion and origin of 11-dehydro-2,3-dinor-thromboxane B2 in man. Chiabrando C; Rivoltella L; Alberti E; Bonollo M; Djurup R; Fanelli R Prostaglandins; 1993 May; 45(5):401-11. PubMed ID: 8321910 [TBL] [Abstract][Full Text] [Related]
33. Simplified assay for the quantification of 2,3-dinor-6-keto-prostaglandin F1 alpha by gas chromatography-mass spectrometry. Daniel VC; Minton TA; Brown NJ; Nadeau JH; Morrow JD J Chromatogr B Biomed Appl; 1994 Mar; 653(2):117-22. PubMed ID: 8205238 [TBL] [Abstract][Full Text] [Related]
34. Biosynthesis of prostacyclin and thromboxane A2 during chronic hypoxaemia in children with cyanotic congenital heart disease. Leonhardt A; Magsaam J; Goldner M; Kühl PG; Seyberth HW Eur J Clin Invest; 1996 Dec; 26(12):1057-61. PubMed ID: 9013079 [TBL] [Abstract][Full Text] [Related]
36. Serum lipoproteins, insulin, and urinary prostanoid metabolites in normal and hypertensive pregnant women. Kaaja R; Tikkanen MJ; Viinikka L; Ylikorkala O Obstet Gynecol; 1995 Mar; 85(3):353-6. PubMed ID: 7862371 [TBL] [Abstract][Full Text] [Related]
37. Changes in prostacyclin, thromboxane A2 and F2-isoprostanes, and influence of eicosapentaenoic acid and antiplatelet agents in patients with hypertension and hyperlipidemia. Yamada M; Omata K; Abe F; Ito S; Abe K Immunopharmacology; 1999 Oct; 44(1-2):193-8. PubMed ID: 10604544 [TBL] [Abstract][Full Text] [Related]
38. Facile method for preparation of 2,3-dinor-6-keto PGF1 alpha, the major urinary metabolite of prostacyclin. Balazy M; Brass EP; Gerber JG; Nies AS Prostaglandins; 1988 Oct; 36(4):421-30. PubMed ID: 3070630 [TBL] [Abstract][Full Text] [Related]
39. Increased synthesis of prostacyclin and thromboxane in human ovarian malignancy. Aitokallio-Tallberg AM; Viinikka LU; Ylikorkala RO Cancer Res; 1988 May; 48(9):2396-8. PubMed ID: 3281748 [TBL] [Abstract][Full Text] [Related]
40. Reduction of urinary 8-epi-prostaglandin F2 alpha during cyclo-oxygenase inhibition in rats but not in man. Bachi A; Brambilla R; Fanelli R; Bianchi R; Zuccato E; Chiabrando C Br J Pharmacol; 1997 Aug; 121(8):1770-4. PubMed ID: 9283716 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]